Subscribe for more episodes: Apple Podcasts | Spotify | Stitcher | Google Podcasts | RSS feed
In the past year, coronavirus disease 2019 (COVID-19) has presented unique challenges to rheumatology practices and care. Although not at the frontline, rheumatologists have had to face difficult decisions regarding, and not limited to, immunosuppressant management and the continuity of care for patients. But with the COVID-19 vaccines at the helm, what does the current rheumatology landscape look like and what is potentially in store for the future of patient care?
In this episode, Amit Ladani, MD, a rheumatologist at West Virginia University Hospital, gives us his perspective on the impact of COVID-19 on rheumatology.
Read the full transcript for this episode here.
Editor’s Note: Please note that this episode was developed and edited before the American College of Rheumatology (ACR) released clinical guidance regarding COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases. We will be providing updated information soon.